Author:
Feller N,Schuurhuis G J,van der Pol M A,Westra G,Weijers G W D,van Stijn A,Huijgens P C,Ossenkoppele G J
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference27 articles.
1. Burnett, AK, Goldstone, AH, Stevens, RM, Hann, IM, Rees, JK, Gray, RG & Wheatley, K. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties. Lancet, (1998). 351, 700–708.
2. San Miguel, JF, Vidriales, MB, Lopez-Berges, C, Diaz-Mediavilla, J, Gutierrez, N, Canizo, C, Ramos, F, Calmuntia, MJ, Perez, JJ, Gonzalez, M & Orfao, A Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification. Blood, (2001). 98, 1746–1751.
3. Venditti, A, Buccisano, F, Del Poeta, G, Maurillo, L, Tamburini, A, Cox, C, Battaglia, A, Catalano, G, Del Moro, B, Cudillo, L, Postorino, M, Masi, M & Amadori, S Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia. Blood, (2000). 96, 3948–3952.
4. Reichle, A, Rothe, G, Krause, S, Zaiss, M, Ullrich, H, Schmitz, G & Andreesen, R Transplant characteristics: minimal residual disease and impaired megakaryocytic colony growth as sensitive parameters for predicting relapse in acute myeloid leukemia. Leukemia, (1999). 13, 1227–1234.
5. van Dongen, JJ, Szczepanski, T, de Bruijn, MA, van den Beemd, MW, de Bruin-Versteeg, S, Wijkhuijs, JM, Tibbe, GJ, van Gastel-Mol, EJ, Groeneveld, K & Hooijkaas, H Detection of minimal residual disease in acute leukemia patients. Cytok Mol Ther, (1996). 2, 121–133.
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献